• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    With Fermion, start the journey of your innovative API.

    Alumis` Envudeucitinib Succeeds in Phase 3 Psoriasis Trial

    GLOBENEWSWIRE

    Alumis Reveals 2025 Financials And Recent Milestones

    GLOBENEWSWIRE

    Alumis Unveils Phase 3 Envudeucitinib Psoriasis Data at 2026

    GLOBENEWSWIRE

    Alumis Announces Phase 3 Breakthrough In Oral Psoriasis Therapy

    INDPHARMAPOST

    Alumis` Envudeucitinib Hits Phase 3 Skin Clearance Goal

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.